Screener
iRadimed IRMD Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue, non-current | 3,757 | 3,978 |
| Total liabilities | $15,875 | 14,158 |
| Stockholders’ equity: | ||
| Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,782,837 shares issued and outstanding as of March 31, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025 | $1 | $1 |
| Additional paid-in capital | 31,020 | 30,386 |
| Retained earnings | 67,493 | 64,231 |
| Total stockholders' equity | 98,514 | 94,618 |
| Total liabilities and stockholders’ equity | $114,389 | $108,776 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's retained earnings?
- iRadimed (IRMD) reported retained earnings of $67.49M in Q1 2026.
- How has iRadimed's retained earnings changed year-over-year?
- iRadimed's retained earnings increased by 13.8% year-over-year, from $59.32M to $67.49M.
- What is the long-term trend for iRadimed's retained earnings?
- Over 5 years (2020 to 2025), iRadimed's retained earnings has grown at a 11.3% compound annual growth rate (CAGR), from $37.67M to $64.23M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about iRadimed's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude